Access in Brazil

Regulatory framework

Brazil's ANVISA has a compassionate-use/expanded-access pathway for unregistered rare-disease drugs.

Typical timeline

For patients in Brazil requesting a specialty drug through {Reserve Meds}, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

1. Patient or physician submits a request with drug name and indication.
2. We verify clinical appropriateness and document eligibility.
3. Treating physician issues prescription and clinical justification.
4. Country-specific regulatory documentation is prepared and submitted.
5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
6. Drug ships cold-chain to destination physician or hospital pharmacy.
7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from Brazil